DHS -OIGPart D/Prescription Drugs

Feds to investigate integrated Part D plans, PBMs

(By Rylee Wilson for Becker’s Hospital Review)

HHS’ Office of Inspector General will investigate the impact of vertically integrated Medicare Part D plans and pharmacy benefit managers on drug prices.

In a notice posted in April on its website, the OIG said it will “determine the impact of related entity transactions within select vertically integrated entities on the prices for covered Part D drugs.” Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.